ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
CureVac works on mRNA vaccine for coronavirus
March 17, 2020German biopharmaceutical company CureVac is working on the development of an mRNA-based vaccine to protect against Covid-19 coronavirus infection. -
Genmab, CureVac Enter Partnership to Develop mRNA-based Antibody Therapeutics
December 23, 2019Genmab and CureVac have entered into a research collaboration and license agreement. This strategic partnership will focus on the research and development of ... -
CureVac collaborates with Yale for mRNA-based pulmonary therapeutics
August 18, 2019The exclusive CRA covers the development of an undisclosed number of novel mRNA-based candidates for pulmonary diseases. -
CureVac and Yale University to develop mRNA-based lung therapies
August 15, 2019Biopharmaceutical firm CureVac has signed a collaborative research agreement with US-based Yale University to discover new therapeutic candidates for the treatment of pulmonary diseases. -
CureVac, Yale Collaborate on Discovery Research
August 14, 2019Will focus on developing novel mRNA-based candidates for pulmonary diseases. -
Lilly, CureVac pen $1.8B mRNA cancer vaccine deal
October 19, 2017Lilly is making a $50 million upfront payment and €45 million equity investment to get the deal up and running.
Pharma Sources Insight January 2025
